GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-Escalation Study

CONCLUSIONS: Adding GEN-1 to standard NAC is safe, appears active and impacts the tumor microenvironment.PMID:34326131 | DOI:10.1158/1078-0432.CCR-21-0360
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research